Outsourcing

Radoslaw Kaczanowski is head of Global Project Management at Recipharm.

Articles

The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

Strategies for Overcoming Common Challenges in Tech Transfer

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Marianna Tcherpakov, PhD, director of Business Development, CMC Services, at Frontage Laboratories, spoke on the CDMO’s role in tackling complex technical challenges to enable startup biotechs solve scale up problems.

BIO 2024: CDMOs Focus on Complex Technical Challenges to Boost Startup Biotechs

Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.

Tech Transfer in the New World of New Modalities

Ahmed Youssef, senior manager, USP Process Development at Ascend, provides insight on tech transfer when developing and manufacturing emerging therapies and new modalities.

Tech Transfer Considerations

Feliza Mirasol is the science editor for 

According to the survey results, 49% of industry respondents are “highly positive” on the contract services sector seeing growth over the next 18 months.

Results from CPHI Milan Survey Find No Favor Among Industry for BIOSECURE Act While Predicting Faster Growth for CDMOs in 2025

Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.

It’s All About the Small Things

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services. 

Agilent Expands Biopharma Offerings with BIOVECTRA Acquisition

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

 Flexibility in Outsourcing Models (BIO 2024)

Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.

Sterling Invests in Expansion of Integrated ADC Services

TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO. 

Contract Manufacturing, General